rs17885785
|
IGF2;IGF2-AS;INS-IGF2
|
Common Variable Immunodeficiency
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
rs17885785
|
IGF2;IGF2-AS;INS-IGF2
|
Diabetes Mellitus, Insulin-Dependent
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
rs17885785
|
IGF2;IGF2-AS;INS-IGF2
|
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
rs17885785
|
IGF2;IGF2-AS;INS-IGF2
|
Autoimmune Diseases
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
rs17885785
|
IGF2;IGF2-AS;INS-IGF2
|
Ulcerative Colitis
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
rs35506085
|
IGF2;IGF2-AS;INS-IGF2
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs35506085
|
IGF2;IGF2-AS;INS-IGF2
|
Lean body mass
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genomics of body fat percentage may contribute to sex bias in anorexia nervosa.
|
30593698 |
2019 |
rs35506085
|
IGF2;IGF2-AS;INS-IGF2
|
Uric acid measurement (procedure)
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.
|
31578528 |
2019 |
rs3741205
|
IGF2;IGF2-AS;INS-IGF2
|
Glomerular Filtration Rate
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.
|
31015462 |
2019 |
rs3741208
|
IGF2;IGF2-AS;INS-IGF2
|
Diabetes Mellitus, Insulin-Dependent
|
T |
0.800 |
GeneticVariation |
GWASCAT |
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.
|
17554260 |
2007 |
rs3741208
|
IGF2;IGF2-AS;INS-IGF2
|
Diabetes Mellitus, Insulin-Dependent
|
T |
0.800 |
GeneticVariation |
GWASDB |
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.
|
17554260 |
2007 |
rs3741210
|
IGF2;IGF2-AS;INS-IGF2
|
Systolic Pressure
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs3741210
|
IGF2;IGF2-AS;INS-IGF2
|
Uric acid measurement (procedure)
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.
|
31578528 |
2019 |
rs3741211
|
IGF2;IGF2-AS;INS-IGF2
|
Malignant neoplasm of endometrium
|
|
0.010 |
GeneticVariation |
BEFREE |
We observed an inverse association with IGFII rs3741211 and endometrial cancer risk (OR=0.79 (95% CI: 0.63, 0.99)) and IGFII rs1004446 and endometrial cancer risk (OR=0.80 (95% CI: 0.68, 0.94)).
|
21078522 |
2011 |
rs3741211
|
IGF2;IGF2-AS;INS-IGF2
|
Endometrial Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
We observed an inverse association with IGFII rs3741211 and endometrial cancer risk (OR=0.79 (95% CI: 0.63, 0.99)) and IGFII rs1004446 and endometrial cancer risk (OR=0.80 (95% CI: 0.68, 0.94)).
|
21078522 |
2011 |